|Articles|June 1, 2016
- BioPharm International-06-01-2016
- Volume 29
- Issue 6
BioPharm International, June 2016 Issue (PDF)
Click the title above to open the BioPharm International June 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Watch Out for the Hangoverover 9 years ago
Scale-Up of Complex Biologicsover 9 years ago
Essentials in Tolerance Design and Setting Specification Limitsover 9 years ago
Make Data Integrity Integral to CGMP Trainingover 9 years ago
Continued Process Verification: State of the Industryover 9 years ago
Scaling Up Progressive Expression Systemsover 9 years ago
Bioprocessing Technology Marches Onover 9 years ago
Controlling Glycosylation for Improved Product Qualityover 9 years ago
Modern Manufacturing Comes of Ageover 9 years ago
Biosimilars: Making the Switch Comes with ChallengesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
